To celebrate Universal Children’s Day on November 20th, the date that marks the signing of the Declaration of the Rights of the Child in 1959, Dr. Robert Ross Russell, EAP representative and Chairman of the European Board of Paediatrics (EBP), is organising a series of events in Cambridge to reflect both the talents and abilities of children. Likewise, the event will also the emphasise the importance of global child health, both for children and for the health of the adults they become.
Under the strapline “Healthy Child, Healthy World – Their Future, Our Responsibility”, there will be a series of activities involving children coupled with information on some of the major issues affecting child health in the UK and across Europe. EAP will support this initiative, and its logo will be featured in all communications and visual items.
Supported by internationally recognised names such as Waheed Arian (Arian Teleheal, winner of 2018 Rotary Peace Prize), Rachel Furley MBE (Bridges to Belarus) and Doug Harper (Development Media International) there are a number of themes, including international child health, research for children, child safety and the childhood origins of adult disease, “Healthy Child, Healthy World” hopes to raise the profile of paediatric health care and involve people in local and international issues.
If you wish to be involved in “Healthy Child, Healthy World” activities (whether in your own country or in the UK), please contact Dr. Robert Ross Russell.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
